⌘K

Login Start Free

Home/Filings/4/0001104659-22-053584

4//SEC Filing

Lorenz Kevin 4

Accession 0001104659-22-053584

CIK 0001429260other

View on SEC.gov Company Profile

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 4:20 PM ET

Size

5.5 KB

Accession

0001104659-22-053584

Insider Transaction Report

Form 4

Period: 2022-01-01

Fortress Biotech, Inc.FBIO

Director

Transactions

Award
COMMON STOCK, PAR VALUE $0.001
2022-01-01+50,000→ 264,572 total

Holdings

COMMON STOCK, PAR VALUE $0.001
(indirect: By Spouse)
10,000

Footnotes (1)

[F1]One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service.

Documents

1 file

4
tm2213913-5_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1

filerCIK 0001772558

Filing Metadata

Form type: 4
Filed: Apr 28, 8:00 PM ET
Accepted: Apr 29, 4:20 PM ET
Size: 5.5 KB

View on SEC.gov